Clinical trials: Potentially Inappropriate Prescribing (PIP)
Potentially Inappropriate Prescribing (PIP)
Potentially Inappropriate Prescribing (PIP) in Long-Term Care (LTC) Patients
The study objectives are: to validate the subsets of Screening Tool of Older People's Prescriptions (STOPP) and Screening Tool to Alert Right Treatment (START), or STOPP/START criteria, and Beers criteria applicable to HAD by…
- Trial name
- PIP in LTC (NCT02523482)
- Where
- 6 sites in Canada
- Volunteers
- 275 people, healthy volunteers welcome
- Sponsor
- Bruyère Health Research Institute.
Prevention, Benzodiazepine Dependence
Electronic Deprescribing Tool for the Prevention of PIP
This study is a cluster randomized control trial aimed to measure the effectiveness of an educational knowledge transfer intervention to prescribers on the discontinuation of two targeted classes: Benzodiazepines…
- Trial name
- NCT03192514
- Testing
- Electronic Deprescribing tool
- Where
- Portugal
- Volunteers
- 280 people
- Sponsor
- University of Beira Interior
Potentially Inappropriate Prescribing (PIP)
The PIP-STOPP Study
The overall objective of the present study will be to describe the occurrence of Potentially Inappropriate Prescribing (PIP) in Ontario's elderly (>65 yrs) population, assess the health and economic burden associated with it, and…
- Trial name
- PIP-STOPP (NCT02555891)
- Volunteers
- 2,000,000 people, healthy volunteers welcome
- Sponsor
- Bruyère Health Research Institute.